The clinically proven drug carvedilol rescued the degradation of β-arrestin 2 and promoted the activation of IFN-β signaling and the antiviral immune response, indicating that it might be an efficient antiviral drug candidate to treat virus infection. This evidence concerns the gene IFNB1 and viral infectious disease.